Wang, H.; Deng, H.; He, J.; Ma, J.; Li, Y.; Lv, H.; Ran, J.; Chen, D.; Li, J.
Evodiamine Inhibits Colorectal Cancer by Downregulating ASS1 via Wnt/β-Catenin/c-MYC Pathway to Block Arginine Synthesis. Pharmaceuticals 2025, 18, 1736.
https://doi.org/10.3390/ph18111736
AMA Style
Wang H, Deng H, He J, Ma J, Li Y, Lv H, Ran J, Chen D, Li J.
Evodiamine Inhibits Colorectal Cancer by Downregulating ASS1 via Wnt/β-Catenin/c-MYC Pathway to Block Arginine Synthesis. Pharmaceuticals. 2025; 18(11):1736.
https://doi.org/10.3390/ph18111736
Chicago/Turabian Style
Wang, Huimin, Hao Deng, Jiaming He, Jing Ma, Yunying Li, Haoyue Lv, Jianhua Ran, Dilong Chen, and Jing Li.
2025. "Evodiamine Inhibits Colorectal Cancer by Downregulating ASS1 via Wnt/β-Catenin/c-MYC Pathway to Block Arginine Synthesis" Pharmaceuticals 18, no. 11: 1736.
https://doi.org/10.3390/ph18111736
APA Style
Wang, H., Deng, H., He, J., Ma, J., Li, Y., Lv, H., Ran, J., Chen, D., & Li, J.
(2025). Evodiamine Inhibits Colorectal Cancer by Downregulating ASS1 via Wnt/β-Catenin/c-MYC Pathway to Block Arginine Synthesis. Pharmaceuticals, 18(11), 1736.
https://doi.org/10.3390/ph18111736
